Enanta Pharmaceuticals (ENTA) Capital Leases (2015 - 2019)

Enanta Pharmaceuticals (ENTA) has 5 years of Capital Leases data on file, last reported at $200000.0 in Q3 2019.

• Quarterly Capital Leases fell 31.74% year-over-year to $200000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $200000.0 (down 31.74% YoY) and the FY2019 annual result came in at $200000.0, down 31.74% from the prior year.
• Capital Leases slipped to $200000.0 in Q3 2019, from $224000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $529000.0 in Q3 2015 to a low of $175000.0 in Q2 2015.
• A 5-year average of $364166.7 and a median of $368500.0 in 2017 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2016 — Capital Leases soared 173.14% — and 2019, when it slumped 31.74%.
• Tracing ENTA's Capital Leases over 5 years: stood at $513000.0 in 2015, then declined by 14.23% to $440000.0 in 2016, then dropped by 18.64% to $358000.0 in 2017, then dropped by 24.3% to $271000.0 in 2018, then slipped by 26.2% to $200000.0 in 2019.
• The last three Capital Leases figures came in at $200000.0 (Q3 2019), $224000.0 (Q2 2019), and $249000.0 (Q1 2019), per Business Quant data.